The knowledge and attitudes of Thai people towards the COVID-19 vaccine Researchers
Keywords:
COVID-19, COVID-19 vaccines, Knowledge, Attitudes, AcceptanceAbstract
Ever since the outbreak of the global pandemic, Covid 19, the world has experienced both physical and economical damage in which vaccines have been the most suitable solution.
This study examines the knowledge, attitude and acceptance of Thai people towards COVID-19 vaccines that are already registered in the country. We have gathered information by doing a cross-sectional study from two questionnaires. The first pressing was on April 3-22 and the second was on May 26 2021. In total, there were 2,866 and 2,513 respondents respectively. The respondents from the first and second questionnaire have similar personal information in terms of address, congenital disease, career, and educational background. Regarding knowledge and understanding of vaccines, in the first survey, Sinovac (CoronaVac)
accounts for the highest amount, followed by Astrazeneca and Johnson & Johnson (79%, 58%, and 54% respectively). In the second questionnaire, the numbers inclined to 91% (Sinovac; CoronaVac), 75.3% (Astrazeneca), and 68.3% (Johnson & Johnson) which shows that there’s a promotion for vaccination at that time. In addition, our team added more question about Moderna and Sinopharm which respondents have a higher score at Sinopharm (84.9%) than Moderna (68.5%)
The acceptance of vaccination among respondents was at a high rate in both the questionnaires. Regarding people who are interested in the vaccine, 85.9% of respondents in the first questionnaire are interested. This value increased significantly to 94% in the second questionnaire which was published during the period of promoting vaccination. As this study shows that the attitudes of people have a tendency to change over time, the results will ultimately be useful when planning vaccine distribution in Thailand.
Downloads
References
Li Q, Guan XH, Wu P, Wang XY, Zhou L, Tong YQ, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. New Engl J Med. 2020;382(13):1199-207
Johns Hopkins University Center for Systems Science and Engineering. (JHUCCSE). (2021). จำนวนผู้ป่วยในไทย, [เข้าถึงเมื่อวันที่ 22 เมษายน 2564]. เข้าถึงได้จาก: https://github.com/CSSEGISandData/COVID-19
ศูนย์บริหารสถานการณ์แพร่ระบาดของโรคติดเชื้อไวรัสโคโรนา 2019 – กระทรวงมหาดไทย (ศบค.มท.). สถานการณ์ COVID-19 ในประเทศไทย,[เข้าถึงเมื่อวันที่ 1 กันยายน 2564]. เข้าถึงได้จาก. https://www.moicovid.com/22/07/2021/uncategorized/4090/
สำนักงานสถิติแห่งชาติ(สสช) (2564). รวม 5 ผลกระทบโควิด-19 ในปี 2020, [เข้าถึงเมื่อวันที่ 27มิถุนายน 2564]. เข้าถึงได้จาก. http://www.nso.
go.th/sites/2014
WH O . C o r o n a v i r u s d i s e a s e 2 0 1 9(COVID-19). Situation Report-51, 2021[เข้าถึงเมื่อวันที่ 30 มกราคม 2564]. เข้าถึงได้จาก. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-
-covid-19.pdf
รัฐบาลไทย. (2563). มาตรการโควิด-19, [เข้าถึงเมื่อวันที่ 21 กรกฎาคม 2564] เข้าถึงได้จาก. https://www.thaigov.go.th/news/contents/details/29344
Nature. (2021). A global survey of potentialacceptance of a COVID-19 vaccine, [เข้าถึงเมื่อวันที่ 25 เมษายน 2564]. เข้าถึงได้จาก. https://www.nature.com/articles/s41591-020-1124-9
Hannah Ritchie, Esteban Ortiz-Ospina, Diana Beltekian, Edouard Mathieu, Joe Hasell, Bobbie Macdonald, Charlie Giattino, Cameron Appel, Max Roser. (2021). Coronavirus (COVID-19) Vaccinations, [เข้าถึงเมื่อวันที่ 30 เมษายน 2564]. เข้าถึงได้จาก. https://ourworldindata.org/covidvaccinations
COVID-19 TRACKER (Thailand), (2564) [เข้าถึงเมื่อวันที่ 1 กันยายน 2564]. เข้าถึงได้จาก https://graphics.reuters.com/world-coronavirus-trackerand-
maps/countries-and-territories/thailand/
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations, (2564) [เข้าถึงเมื่อวันที่ 29
มิถุนายน 2564]. เข้าถึงจาก https://www.who.int/news/item/01-06-2021-who-validates-sinovaccovid-19-vaccine-for-emergency-use-and-issuesinterim-policy-recommendations
Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39:1148-56.
Reuben RC, Danladi MMA, Saleh DA, Ejembi PE. Knowledge, Attitudes and Practices Towards COVID-19: An Epidemiological Survey in North-Central Nigeria. J Community Health. 2021;46:457-70.
Sherman SM, Smith LE, Sim J, Amlot R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vacc Immunother. 2021;17:1612-21.
Li XH, Chen L, Pan QN, Liu J, Zhang X, Yi JJ, et al. Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China. Hum Vaccin Immunother. 2021:1-9.
Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ, Sydney Health Literacy Lab C-g. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21:318-9.
Holzmann-Littig C, Braunisch MC, Kranke P, Popp M, Seeber C, Fichtner F, et al. COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany. Vaccines (Basel). 2021;9(7).
Goncu Ayhan S, Oluklu D, Atalay A, Menekse Beser D, Tanacan A, Moraloglu Tekin O, et al. COVID-19 vaccine acceptance in pregnant women. Int J Gynaecol Obstet. 2021;154:291-6.
Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36:197-211.
Kelekar AK, Lucia VC, Afonso NM, Mascarenhas AK. COVID-19 vaccine acceptance and hesitancy among dental and medical students. J Am Dent Assoc. 2021;152:596-603.
Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS One. 2021;16:e0256110.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
